BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19530746)

  • 21. A History of Drug-Induced Torsades de Pointes Is Associated With T-wave Morphological Abnormalities.
    Bhuiyan TA; Graff C; Kanters JK; Melgaard J; Toft E; Kääb S; Struijk JJ
    Clin Pharmacol Ther; 2018 Jun; 103(6):1100-1106. PubMed ID: 28940299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-Wave Morphology Analysis in Congenital Long QT Syndrome Discriminates Patients From Healthy Individuals.
    Porta-Sánchez A; Spillane DR; Harris L; Xue J; Dorsey P; Care M; Chauhan V; Gollob MH; Spears DA
    JACC Clin Electrophysiol; 2017 Apr; 3(4):374-381. PubMed ID: 29759450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations.
    Lupoglazoff JM; Denjoy I; Berthet M; Neyroud N; Demay L; Richard P; Hainque B; Vaksmann G; Klug D; Leenhardt A; Maillard G; Coumel P; Guicheney P
    Circulation; 2001 Feb; 103(8):1095-101. PubMed ID: 11222472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.
    Sugrue A; Kremen V; Qiang B; Sheldon SH; DeSimone CV; Sapir Y; Striemer BL; Brady P; Asirvatham SJ; Ackerman MJ; Friedman P; Noseworthy PA
    Cardiovasc Drugs Ther; 2015; 29(5):433-41. PubMed ID: 26411977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.
    Extramiana F; Badilini F; Sarapa N; Leenhardt A; Maison-Blanche P
    J Clin Pharmacol; 2007 Sep; 47(9):1129-37. PubMed ID: 17656619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of β-blockers on ventricular repolarization documented by 24-hour electrocardiography in long QT syndrome type 2.
    Koponen M; Marjamaa A; Väänänen H; Tuiskula AM; Kontula K; Swan H; Viitasalo M
    Heart Rhythm; 2022 Sep; 19(9):1491-1498. PubMed ID: 35525424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalol.
    Fossa AA; Wisialowski T; Crimin K; Wolfgang E; Couderc JP; Hinterseer M; Kaab S; Zareba W; Badilini F; Sarapa N
    Ann Noninvasive Electrocardiol; 2007 Oct; 12(4):338-48. PubMed ID: 17970959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial.
    Eveleens Maarse BC; Graff C; Kanters JK; van Esdonk MJ; Kemme MJB; In 't Veld AE; Jansen MAA; Moerland M; Gal P
    Br J Clin Pharmacol; 2022 Mar; 88(3):1054-1062. PubMed ID: 34327732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epinephrine-induced T-wave notching in congenital long QT syndrome.
    Khositseth A; Hejlik J; Shen WK; Ackerman MJ
    Heart Rhythm; 2005 Feb; 2(2):141-6. PubMed ID: 15851286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in cardiac repolarization following intravenous sotalol administration.
    Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Cardiology; 2010; 116(3):219-25. PubMed ID: 20693799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I(Kr) channel blockade to unmask occult congenital long QT syndrome.
    Jeyaraj D; Abernethy DP; Natarajan RN; Dettmer MM; Dikshteyn M; Meredith DM; Patel K; Allareddy RR; Lewis SA; Kaufman ES
    Heart Rhythm; 2008 Jan; 5(1):2-7. PubMed ID: 18273958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
    Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal variability of QT interval and changes in T wave morphology in dogs as markers of the clinical risk of drug-induced proarrhythmia.
    Hanton G; Yvon A; Racaud A
    J Pharmacol Toxicol Methods; 2008; 57(3):194-201. PubMed ID: 18472280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.